Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Monoclonal antibody prepared from African swine fever virus truncated protein p54 and application of monoclonal antibody

A technology of African swine fever virus and monoclonal antibody, which is applied in a field, can solve the problems of obstruction, chromosome loss, and lack of secretion of single antibody, etc., and achieve the effect of shortening the test time, simple operation steps, and good immunogenicity

Active Publication Date: 2020-10-30
HUAZHONG AGRI UNIV
View PDF7 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Secondly, after immunization with high-quality antigens, there are obstacles in the process of cell fusion and positive clone cell selection. For example, although the success rate of cell fusion is high, the successfully fused cells do not have the ability to secrete a single antibody; During the process, the status of some hybridoma cells was unstable. After multiple subcloning, the chromosomes were lost and could not continue to secrete a single antibody; after the hybridoma cells secreting a single antibody were obtained, ascites was obtained by immunizing mice, and the ascites titer obtained Not high; and after some monoclonal antibodies are prepared, because the recognized target is inconsistent with the serum to be tested, it is impossible to establish a blocking Elisa detection method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody prepared from African swine fever virus truncated protein p54 and application of monoclonal antibody
  • Monoclonal antibody prepared from African swine fever virus truncated protein p54 and application of monoclonal antibody
  • Monoclonal antibody prepared from African swine fever virus truncated protein p54 and application of monoclonal antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Preparation of anti-ASFV p54 monoclonal antibody and obtaining secreted hybridoma cell lines:

[0023] The antigen of the present invention is African swine fever virus truncated protein p54 (shown in SEQ ID NO.1), and the indirect ELISA detection kit prepared by using the protein as antigen coating can accurately detect whether the sample contains African swine fever virus At the same time, compared with the Spanish detection kit recommended by OIE, the specificity of the indirect ELISA kit established by this antigen is comparable to it, and the sensitivity is better than that of the Spanish detection kit.

[0024] 1. Animal immunity

[0025] Get 200 μ g of African swine fever virus truncated protein p54 (shown in SEQ ID NO.1) and Freund's complete adjuvant of the same volume, use a syringe after emulsifying with an emulsifier to carry out multiple injections on the back of 6-8 week old BALB / c mice Point injection, 14 days later for the second immunization. Second i...

Embodiment 2

[0035] Example 2: Preparation of ascites and identification of monoclonal antibody characteristics

[0036] 1. Ascites preparation

[0037] Take 8-week-old BALB / c mice, intraperitoneally inject Freund's incomplete adjuvant, 0.5mL / mouse; 7-10 days later, intraperitoneally inject hybridoma cells 4-4C in logarithmic growth phase diluted with basal medium, 1.2×10 6 Individual / only; observe the state of the mice. After 7-14 days, the abdomen of the mouse was obviously bulged, and the ascites was collected from the abdominal cavity with a 16# needle, centrifuged at 1500r / min for 10min, the fat tissue was removed, the supernatant was absorbed, and stored at -20°C for later use.

[0038] 2. Characterization of monoclonal antibody

[0039] 2.1 Potency determination

[0040] The recombinant protein p54 was coated, placed overnight at 4°C, washed 3 times with PBST, and blocked with blocking solution. The coated plate was placed in a 37°C incubator, incubated for 2 hours, washed 3 tim...

Embodiment 3

[0048] Example 3: Identification of reactivity of monoclonal antibodies with whole virus antigens

[0049] 3.1 ELISA method to detect the reactogenicity of ASFV and obtained ascites

[0050] Dilute the purified African swine fever whole virus (purified virus concentration is 0.8mg / mL) at 1:800, coat at 4°C overnight, wash 3 times with PBST, seal the coated plate with blocking solution, and place Incubate at 37°C for 2 hours. The ascites obtained in Example 2 was diluted 2 times starting from 1:100 until 1:12800, and negative and positive controls were set at the same time, 100 μl per well, placed in a 37°C incubator, incubated for 30min, washed 5 times with PBST, and added to the working Goat anti-mouse HRP-IgG with a concentration of 1:5000, placed in a 37°C incubator, incubated for 30 minutes, washed 5 times with PBST, added TMB to avoid light for 10 minutes, hydrofluoric acid terminated the reaction, and read OD 630nm . The conditions for the establishment of this method...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of clinical immunology, and discloses a monoclonal antibody prepared from African swine fever virus truncated protein p54 and application of the monoclonalantibody. The monoclonal antibody clone antibody 4-4C is finally obtained by immunizing the effectively truncated African swine fever virus protein p54 and systematically screening hybridoma. The obtained monoclonal antibody can react with the African swine fever totivirus to meet the basic requirements of the monoclonal antibody; in addition, the monoclonal antibody is good in specificity and has no cross reaction with other proteins of the African swine fever virus; in addition, after the monoclonal antibody is detected by Elisa, the titer of the monoclonal antibody reaches up to 1600000; finally, the monoclonal antibody has a blocking effect, the established blocking Elisa detection method has a detection effect equivalent to that of a Spanish detection kit recommended by OIE, the detection time is shortened, and the monoclonal antibody has the capacity of detecting the antibody level of African swine fever for pig farms.

Description

technical field [0001] The invention belongs to the technical field of clinical immunology, relates to the technical field of detection and identification of African swine fever virus, in particular to a monoclonal antibody prepared from the truncated protein p54 of African swine fever virus, and also relates to a monoclonal antibody secreting African swine fever virus The hybridoma cell of cloning antibody also relates to the application of the monoclonal antibody prepared by truncating protein p54 in the preparation and detection of African swine fever virus kit. Background technique [0002] African swine fever is an acute and highly contagious zoonotic disease of pigs caused by African swine fever virus. It has the characteristics of high incidence, short course of disease and high mortality. African swine fever virus belongs to the African swine fever virus family, double-stranded DNA virus, its genome is large, 170-190bp, and the gene is variable, there is a variable r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/20C07K16/08G01N33/569G01N33/577
CPCC07K16/081C07K2317/35G01N33/56983G01N33/577G01N2333/01
Inventor 金梅林杨永张强赵亚孙小美吕长杰杨丽
Owner HUAZHONG AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products